| |
| |
|
| Insider
Information: |
Daskal Ilan |
| Relationship: |
EVP, Chief Financial O... |
| City: |
El Segundo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
412,486 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$685,987 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
412,486 |
|
|
| Total
Value |
$685,987 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -105.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
International Rectifier Corp |
IRF |
Executive Vice Preside... |
2015-01-13 |
0 |
2009-10-06 |
0 |
Premium* |
|
|
Cepheid |
CPHD |
EVP, Chief Financial O... |
2015-04-09 |
10,000 |
2015-04-09 |
0 |
Premium* |
|
|
IXIA |
XXIA |
Director |
2017-04-18 |
0 |
2015-08-07 |
0 |
Premium* |
|
|
Sunedison Inc |
SUNE |
EVP & CFO Designee |
2016-04-08 |
400,000 |
2016-04-08 |
0 |
Premium* |
|
|
Natus Medical Inc |
BABY |
Director |
2022-07-21 |
0 |
2020-03-18 |
0 |
Premium* |
|
|
Bio Rad Laboratories Inc |
BIO |
EVP, Chief Financial O... |
2023-09-02 |
2,486 |
2020-04-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
542 |
2,755 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2023-09-02 |
4 |
D |
$394.60 |
$106,147 |
D/D |
(269) |
2,486 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2023-09-01 |
4 |
D |
$394.60 |
$177,175 |
D/D |
(449) |
2,213 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,150 |
2,422 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2023-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
1,736 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2023-04-08 |
4 |
D |
$466.24 |
$113,296 |
D/D |
(243) |
1,493 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2022-09-02 |
4 |
D |
$478.32 |
$128,668 |
D/D |
(269) |
953 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2022-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
541 |
1,222 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
455 |
907 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2022-09-01 |
4 |
D |
$486.25 |
$109,893 |
D/D |
(226) |
681 |
0 |
- |
|
| BABY |
Natus Medical Inc |
Director |
– • – |
2022-07-21 |
4 |
D |
$33.50 |
$634,390 |
D/D |
(18,937) |
0 |
0 |
- |
|
| BABY |
Natus Medical Inc |
Director |
– • – |
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,075 |
18,937 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2022-04-08 |
4 |
D |
$597.16 |
$153,470 |
D/D |
(257) |
452 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2022-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
709 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2021-09-03 |
4 |
S |
$820.06 |
$221,416 |
D/D |
(270) |
9 |
0 |
% |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2021-09-02 |
4 |
D |
$825.77 |
$222,132 |
D/D |
(269) |
279 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2021-09-02 |
4 |
S |
$828.00 |
$447,121 |
D/D |
(540) |
7 |
0 |
% |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2021-09-02 |
4 |
OE |
$0.00 |
$283,122 |
D/D |
1,081 |
548 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2021-08-04 |
4 |
S |
$750.85 |
$1,729,241 |
D/D |
(2,300) |
7 |
0 |
% |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2021-08-04 |
4 |
OE |
$309.84 |
$433,776 |
D/D |
1,400 |
2,307 |
0 |
- |
|
| BABY |
Natus Medical Inc |
Director |
– • – |
2021-06-17 |
4 |
A |
$28.77 |
$150,007 |
D/D |
5,214 |
13,862 |
0 |
- |
|
| BABY |
Natus Medical Inc |
Director |
– • – |
2021-06-11 |
4 |
S |
$27.46 |
$68,650 |
D/D |
(2,500) |
8,648 |
0 |
% |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2021-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
1,157 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Financial Officer |
• – – |
2021-04-08 |
4 |
D |
$592.23 |
$148,058 |
D/D |
(250) |
907 |
0 |
- |
|
| BABY |
Natus Medical Inc |
Director |
– • – |
2020-06-19 |
4 |
A |
$21.07 |
$75,009 |
D/D |
3,560 |
11,148 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
